Navigation Links
ViroPharma to Present at Three October Healthcare Conferences
Date:10/1/2008

EXTON, Pa., Oct. 1 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the third annual JMP Securities Healthcare Focus Conference at 2:30 P.M. ET on Monday, October 6, 2008. The conference is being held at the Le Parker Meridien Hotel in New York.

ViroPharma also announced that Robert Doody, manager, corporate communications of ViroPharma, will present at the Maxim Group Growth Conference at 10:30 A.M. ET on Tuesday, October 7, 2008. The conference is being held at the Grand Hyatt in New York.

William Roberts, vice president, corporate communications of ViroPharma, will present at the second annual Natixis Bleichroeder Hidden Gems Conference at 8:30 A.M. ET on Monday, October 13, 2008. The conference is being held at the Waldorf=Astoria in New York.

ViroPharma's presentations will be webcast live for investors through http://www.viropharma.com and available for a period of 14 days following the conferences.

About ViroPharma Incorporated

ViroPharma Incorporated is committed to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R) approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in infectious diseases including cytomegalovirus (CMV) and non-toxigenic C. difficile (NTCD).


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ViroPharma to Present at Three September Healthcare Conferences
2. ViroPharma To Acquire Lev Pharmaceuticals
3. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
4. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
5. ViroPharma to Present at Two Upcoming Healthcare Conferences
6. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
7. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
8. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
9. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
10. ViroPharma to Present at the BIO CEO & Investor Conference
11. ViroPharma Provides 2008 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national ... Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based ... selected for membership in ARCS Alumni Hall of Fame . ASTER Labs ...
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
Breaking Biology Technology:
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
(Date:4/18/2017)... -- Socionext Inc., a global expert in SoC-based imaging and computing solutions, ... which features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ... will be showcased during the upcoming Medtec Japan at Tokyo Big ... Las Vegas Convention Center April 24-27. ... Click here for an image of ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):